BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26585299)

  • 1. Connexin Controls Cell-Cycle Exit and Cell Differentiation by Directly Promoting Cytosolic Localization and Degradation of E3 Ligase Skp2.
    Shi Q; Gu S; Yu XS; White TW; Banks EA; Jiang JX
    Dev Cell; 2015 Nov; 35(4):483-96. PubMed ID: 26585299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 inversely correlates with p27 and tuberin in transformed cells.
    Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells.
    Egozi D; Shapira M; Paor G; Ben-Izhak O; Skorecki K; Hershko DD
    FASEB J; 2007 Sep; 21(11):2807-17. PubMed ID: 17475922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation.
    Jeong K; Murphy JM; Ahn EE; Lim SS
    Cardiovasc Res; 2022 Mar; 118(4):1150-1163. PubMed ID: 33839758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skp2 promotes adipocyte differentiation via a p27Kip1-independent mechanism in primary mouse embryonic fibroblasts.
    Okada M; Sakai T; Nakamura T; Tamamori-Adachi M; Kitajima S; Matsuki Y; Watanabe E; Hiramatsu R; Sakaue H; Kasuga M
    Biochem Biophys Res Commun; 2009 Feb; 379(2):249-54. PubMed ID: 19109928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
    Shen L; Qu X; Li H; Xu C; Wei M; Wang Q; Ru Y; Liu B; Xu Y; Li K; Hu J; Wang L; Ma Y; Li M; Lai X; Gao L; Wu K; Yao L; Zheng J; Zhang J
    Oncogene; 2018 Mar; 37(13):1759-1774. PubMed ID: 29343851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
    Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
    Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells.
    Lee JG; Kay EP
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):189-96. PubMed ID: 18172092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
    Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skp2 contributes to cell cycle progression in trophoblast stem cells and to placental development.
    Yamauchi Y; Nita A; Nishiyama M; Muto Y; Shimizu H; Nakatsumi H; Nakayama KI
    Genes Cells; 2020 Jun; 25(6):427-438. PubMed ID: 32267063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression.
    Xu SY; Wang F; Wei G; Wang B; Yang JY; Huang YZ; Zhang L; Zheng F; Guo LY; Wang JN; Tang JM
    Cancer Gene Ther; 2013 Dec; 20(12):690-4. PubMed ID: 24336114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
    Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
    Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 Downregulation.
    Borriello A; Naviglio S; Bencivenga D; Caldarelli I; Tramontano A; Speranza MC; Stampone E; Sapio L; Negri A; Oliva A; Sinisi AA; Spina A; Della Ragione F
    Oxid Med Cell Longev; 2016; 2016():2481865. PubMed ID: 26682002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells.
    Lee JJ; Lee JS; Cui MN; Yun HH; Kim HY; Lee SH; Lee JH
    Cell Death Dis; 2014 Nov; 5(11):e1537. PubMed ID: 25412315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear translocation of Skp2 facilitates its destruction in response to TGFβ signaling.
    Hu D; Liu W; Wu G; Wan Y
    Cell Cycle; 2011 Jan; 10(2):285-92. PubMed ID: 21212736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skp2-mediated degradation of p27 regulates cell cycle progression in compressed human bladder smooth muscle cells.
    Chen L; Wu T; Wei TQ; Wei X; Li SF; Wang KJ; Li H
    Kaohsiung J Med Sci; 2014 Apr; 30(4):181-6. PubMed ID: 24656158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
    Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
    Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.